GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PRF Technologies PRFX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.81

-6.84%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About PRF Technologies

Its shares trade under the ticker PRFX. It has been listed since 1 September 2020. In the fiscal year to 31 December 2024, it reported a net loss of $14.6m. At that date it held total assets of $4.5m and shareholders' equity of $1.8m.

PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
1 Sept 2020
Employees
6
Head office
65 YIGAL ALON ST., TEL AVIV
Incorporated in
L3
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer

Leadership

Pay as last reported

  • Dr. Ehud GellerChairman of the Board, since 2008$235,000
  • Mr. Ilan HadarChief Executive Officer, Chief Financial Officer$770,000
  • DR. Sigal AvielChief Operating Officer$302,000
  • Prof. Eli HazumChief Technology Officer, Director, since 2019$230,000
  • Mrs. Rita KeynanVice President - Pharmaceutical Operations$460,000
  • Dr. Ellen BaronIndependent Director
  • Mr. Efi Cohen-AraziIndependent Director
  • Mr. Augustine LawlorIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • PRF Technologies Ltd has a focused sector in Health Care with a specific industry in Pharmaceuticals.
  • The company has a clear product focus on reformulating established pain therapeutics.
  • PRF Technologies Ltd has a small but dedicated team of 6 employees.

Weaknesses

  • The company has a very small employee count of only 6 employees.
  • The company's IPO was in 2020, indicating a relatively new market presence.
  • The company's website is painreform.com, which may not be widely recognized.

Opportunities

  • The company can expand its reformulation technology to other therapeutic areas beyond pain management.
  • There is potential to increase market share in the pharmaceutical sector through innovative reformulations.
  • The company can leverage its focus on minimizing adverse effects to attract healthcare providers.

Threats

  • The company's small size may limit its ability to compete with larger pharmaceutical firms.
  • The company's reliance on reformulating established therapeutics may face regulatory challenges.
  • The company's website domain may not be easily discoverable by potential customers.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.